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OBJECTIVES This study was designed to determine the role of cellular and humoral immune responses to
heat shock protein 65 (HSP65) in murine atherosclerosis.
BACKGROUND Inflammatory processes appear to influence the progression of atherosclerosis. Immunization
with HSP65 was previously shown to induce arteriosclerosis in rabbits and to enhance
fatty-streak formation in mice. However, it has not been demonstrated directly whether
HSP65-reactive antibodies and lymphocytes are separately capable of influencing lesion
formation.
METHODS Low density lipoprotein-receptor deficient (LDL-RD) mice were immunized with HSP65 or
control bovine serum albumin (BSA). Lymph-node cells, splenocytes and immunoglobulin G
(IgG) were obtained from the immunized mice and transferred separately to six groups of
syngenic LDL-RD mice.
RESULTS Adoptive transfer of HSP65-reactive lymph node cells increased fatty-streak formation in
comparison with mice treated with BSA-primed cells. Similarly, transfer of splenocytes
reactive with HSP65 led to enhanced fatty-streak generation compared with mice injected
with BSA-sensitized splenocytes. Repeated intraperitoneal administration of IgG from serum
of HSP65-immunized mice (every 10 days) enhanced fatty-streak formation in mice in
comparison with their anti-BSA-IgG injected littermates.
CONCLUSIONS Antibodies and lymphocytes reactive to HSP65 promote fatty-streak formation in mice,
providing direct evidence for the proatherogenic properties of cellular and humoral immunity
to HSP65. (J Am Coll Cardiol 2001;38:900–5) © 2001 by the American College of
Cardiology
Atherosclerosis is a process in which inflammatory reactions
appear to play a dominant role (1,2). This notion has been
further extended to incriminate autoimmune factors as
involved in the progression of atherosclerotic plaque (3). As
such, modified lipoproteins (oxidized low density lipopro-
tein [LDL]) and cross-reactive autoantigens (heat shock
protein [HSP] 60/65) have been proposed as triggering
antigens (3).
The HSPs are a family of molecules expressed by cells in
response to stressful insults, and display a high degree of
sequence preservation from bacteria to humans. Heat shock
proteins have been named “chaperonines” because of their
role in maintenance of protein stability by protecting against
unfolding (4,5). However, their overexpression, that of
HSP60 in particular, has been shown to be associated with
a variety of autoimmune disorders in experimental animals
(6). In recent years, it has been shown by a set of clinical and
experimental studies that the immune response against
bacterial HSP65 cross-reacts with mammalian HSP60 and
could play a proatherogenic role in animals and humans (3).
According to this hypothesis, infectious or toxic agents
trigger an anti-HSP65 immune response that cross-reacts
with the host HSP60 and results in acceleration of athero-
sclerosis. The principal experimental evidence for the role of
HSP60/65 autoimmunity in atherosclerosis stems from two
animal studies showing enhancement in arteriosclerosis in
rabbits (7) and in fatty-streak formation in C57BL/6 mice
fed an atherogenic diet (8).
Partial characterization of the mechanisms involved in
promotion of atherogenesis has been demonstrated by
showing the ability of bacterial and human HSP60 to
activate vascular endothelium and smooth muscle cells and
to modulate macrophage TNF-alpha and matrix metallo-
proteinase expression (9,10). Additionally immunoglobulin
G (IgG) antibodies against HSP60 have been shown to
mediate endothelial cytotoxicity (11,12). However, no study
to date has demonstrated the impact of antigen (HSP65)-
specific humoral and cellular mechanisms on atherogenesis
in vivo.
In this study we analyze separately the roles of the cellular
and humoral immune responses to HSP65 and determine
their relative contribution to early atherosclerosis in LDL-
receptor deficient (LDL-RD) mice.
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MATERIALS AND METHODS
Mice. Twelve-week-old female LDL-RD mice (hybrids of
the C57BL/6J and 129Sv strains) were created by homol-
ogous recombination as described by Ishibashi et al. (13).
The mice were obtained from the Jackson Laboratory (Bar
Harbor, Maine) and bred at the local animal house by
repeated (at least seven generations) brother-sister matings.
Low density lipoprotein receptor deficiency was confirmed
by repeated polymerase chain reactions (13). The mice were
maintained on 12-h dark/12-h light cycles and were allowed
access to food and water ad libitum. Animals were kept in
standard conditions.
Study design. EXPERIMENT 1. Low density lipoprotein
receptor-deficient mice were immunized subcutaneously in
the hind footpad with 25 mg of HSP65 or control bovine
serum albumin (BSA) (25 mg) emulsified in incomplete
Freund’s adjuvant (IFA). The mice were boosted twice
under the same protocol following three and six weeks and
were fed a chow diet. Twelve weeks after the first immuni-
zation, hearts were removed for determination of athero-
sclerosis and spleen cells from each group were pooled and
collected. Splenocytes obtained from a single cell suspension
were incubated for three days in the presence of Concavalin
A (Sigma Chemical). Cell viability was evaluated by Trypan
blue in each of the experiments. The cells (1 3 107) from
HSP65 or BSA-immunized mice were transferred by a
single intraperitoneal injection to nontreated female
LDL-RD mice (10 per group).
EXPERIMENT 2. Draining lymph node cells were removed
from mice that were immunized subcutaneously once in the
hind footpad with either HSP65 or BSA (50 mg/mouse).
The lymph node cells from each group (HSP65 or BSA)
were collected and pooled, after which they were stimulated
in vitro with HSP65 (10 mg/ml) for three days. Lympho-
cytes were then transferred by a single intraperitoneal
injection to 12-week-old nontreated female mice (1 3
107/mouse). The recipient mice injected with lymph-node
cells from either HSP65- or BSA-immunized mice were fed
a chow diet and sacrificed 12 weeks afterwards.
To exclude the possibility of graft-versus-host disease
that would likely influence atherosclerosis, mice were clin-
ically assessed during the study at weekly intervals for the
following parameters: weight loss, fur texture, posture, skin
integrity and eye inflammation.
EXPERIMENT 3. Total IgG was purified from HSP65- or
BSA-immunized mice (the mice that served as splenocyte
donors and contained hyperimmune serum). Twelve-week-
old LDL-RD mice were injected intraperitoneally with IgG
from serum of HSP65 or BSA-immunized mice (100
mg/mouse per dose) every 10 days until sacrifice, 12 weeks
following the initial injection. Such a protocol was shown by
a preliminary experiment to yield consistently high levels of
anti-HSP65 antibodies in the sera of the mice throughout
the 12 weeks of the experiment.
The study was aimed at evaluating fatty streaks rather
than advanced atherosclerosis induced by an atherogenic
diet, as early lesions are more likely to be influenced by
immunologic manipulations (8,14). Furthermore, avoidance
of high-fat diet feeding prevents excessive LDL cholesterol
elevations and keeps the LDL-RD mice at ranges of
cholesterol approximating human levels (;180 mg/dl).
Cholesterol level determinations. Total plasma choles-
terol levels were determined by an automated enzymatic
technique (Boehringer Mannheim, Germany) at the end of
the experiment.
Proliferation assays. Splenocytes (experiment 1) or drain-
ing lymph-node cells (experiment 2) were collected from
immunized mice. The assays were performed as previously
described (8), with minor modifications. Briefly, 1 3 106
cells/ml were incubated in triplicates for 72 h in 0.2 ml of
culture medium in microtiter wells in the presence of
different concentrations of HSP65. Proliferation was mea-
sured by the incorporation of [3H] thymidine into deoxyri-
bonucleic acid during the final 12 h of incubation. The
results were computed as stimulation index (SI): the ratio of
the mean counts per minute (cpm) of the antigen to the
mean background cpm obtained in the absence of the
antigen. Standard deviation was always ,10% of the mean
cpm.
Detection of anti-HSP65 antibodies by enzyme-linked
immunosorbent assay (ELISA). Recombinant mycobac-
terial HSP65 or recombinant HSP60 (purchased from
Stressgene) in phosphate-buffered saline (PBS) (pH 7.2)
was coated onto flat-bottom 96-well ELISA plates (Nunc
Maxisorp, Denmark) by overnight incubation (1 mg/ml).
After washings with 0.02% PBS Tween and blocking with
1% BSA in PBS, sera or IgG were added in different
concentrations and incubated for 1 h at room temperature.
Alkaline-phosphatase-conjugated goat antimouse IgG
(DAKO Ltd., High Wycombe, United Kingdom) was
added and incubated for 1 h at room temperature followed
by four washings with PBS/Tween. After extensive wash-
ing, 1 mg/ml p-nitrophenyl-phosphate (Sigma) in 50 mM
carbonate buffer containing 1 mM MgCl2 pH 9.8 was
added as a substrate. The reaction was stopped after 30 min
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by adding 1 M of NaOH. The optical density (OD) was
read at a 405 nm wavelength in a Titertek ELISA reader.
Purification of mouse IgG. Immunoglobulin G from
pooled sera of either HSP65 or BSA hyperimmunized mice
was purified by protein G-Sepharose column (Pharmacia,
Uppsala, Sweden).
Assessment of atherosclerosis. Quantification of athero-
sclerotic fatty-streak lesions was done by calculating the
lesion size in the aortic sinus as previously described (15).
The heart and upper section of the aorta were removed from
the animals and the peripheral fat cleaned carefully. The
upper section was embedded in O.C.T compound (Miles
Inc., Elkhart, Indiana) and frozen. Every other section (5 to
10 mm thick) throughout the aortic sinus (400 mm) was
taken for analysis. Sections were evaluated for fatty-streak
lesions after staining with oil-red O. Lesion area per section
was counted with a grid by an observer unfamiliar with the
tested specimen.
Immunohistochemistry. Immunohistochemical staining
of 5-mm thick cryostat-cut sections of the aortic sinus was
done as follows. Sections were fixed in cold acetone for
10 min, air-dried and washed twice in TBS. Endogenous
peroxidase activity was blocked by incubating slides in a
solution of 3% hydrogen peroxidase for 5 min. All incuba-
tions were performed at room temperature in humidified
chambers. Slides were incubated with the appropriate pri-
mary antibody overnight, followed by 4 to 6 h of incubation
with secondary horseradish peroxidase-labeled goat antirat
IgG antibody (1:200 dilution in TBS). Sections were
visualized by chromogenic detection (AEC substrate system
No. K0697; Dako Corp, Carpinteria, California). AEC was
used as a chromogen. After treatment, sections were washed
with TBS and counterstained with hematoxylin. Vascular
cell adhesion molecule-1 (VCAM-1), intercellular adhesion
molecule (ICAM-1) and E-Selectin were detected using the
respective rat monoclonal antimurine antibodies (antibody
dilution was 1:100, No. 1510-01; Southern Biotechnology
Associates, Inc., Birmingham, Alabama). Primary antibod-
ies bound to tissue were visualized after the binding of
antirat immunoglobulin coupled to horseradish peroxidase.
Control slides were incubated with nonspecific primary
antisera, or in some cases without the primary antibody. In
no case did control slides show a positive signal. Vascular
cell adhesion molecule-1 surface coverage was expressed as
the plaque positive area divided by the total plaque area as
previously described (16). Six sections from six different
mice in the HSP65 or BSA lymph node cell transfer
recipients were chosen for analysis.
For assessment of the expression of HSP60/65 on endo-
thelial cells, frozen aortic sinus sections were incubated with
IgG from HSP65- (shown to be cross-reactive with
HSP60) or BSA-immunized mice and probed with the
Histomouse kit in accord with the manufacturer’s instruc-
tions.
Statistical analysis. Differences between individual param-
eters were compared using the two-sided Student t test; p ,
0.05 was considered statistically significant. Results are
expressed as mean 6 SEM.
RESULTS
Preliminary studies have shown that immunization with
BSA (emulsified in IFA) did not promote fatty-streak
formation in LDL-RD mice in comparison with nonim-
munized mice. Thus, we have chosen BSA as a control
irrelevant antigen throughout the experiments.
All mice appeared healthy throughout the experiments
and no signs of graft-versus-host disease (weight loss,
hunching, baldness, loss of skin integrity or eye inflamma-
tion) were evident.
Transfer of spleen cells, lymph node cells or antibodies
to HSP65 does not alter cholesterol levels. Administra-
tion of splenocytes did not influence the cholesterol levels in
LDL-RD mice. Mean cholesterol levels for the group of
mice injected with HSP65-lymph node cells were 194 6 33
mg/dl in comparison with values of 186 6 29 in the T-BSA
group. Levels were also similar in the Spl-HSP65 (injected
with total splenocytes from HSP65-immunized animals)
mice (190 6 26 mg/dl) as compared with the Spl-BSA mice
(193 6 31 mg/dl). Immunoglobulin G administration did
not affect cholesterol levels (196 6 34 mg/dl in the
IgG-HSP65 mice and 189 6 29 mg/dl in the IgG-BSA
mice).
Characterization of HSP65 reactivity in the transferred
cells and IgG. The reactivity of lymphocytes from the
HSP65-immunized mice and that of the purified IgG to
HSP65 was characterized before their transfer to the non-
injected mice.
Reactivity to HSP65 (25 mg/ml) of lymphocytes obtained
from mice that were immunized with HSP65 was pro-
nounced, with a mean SI of 5.6 6 1.2 (Fig. 1A). The
proliferative response to HSP65 (25 mg/ml) of splenocytes
from mice repeatedly immunized with HSP65 was signifi-
cant, with a mean SI of 4.9 6 0.9 (Fig. 1B). In vitro
stimulation with (mammalian) HSP60 (25 mg/ml) was also
capable of inducing proliferation of HSP65-injected lymph
node cells (mean SI of 3.2 6 0.8) and splenocytes (SI of
2.9 6 0.7), confirming the cross-reactivity between myco-
bacterial HSP65 and mammalian HSP60.
Immunoglobulin G binding to solid-phase-bound
HSP65 was significant, starting from OD values of 1.7 6
0.3 at a concentration of 100 mg/ml (Fig. 1C). To confirm
cross-reactivity, plates were coated, in parallel, with recom-
binant HSP 60. Mean IgG binding to HSP60 at a concen-
tration of 100 mg/ml was 0.8 6 0.2 (OD 405 nm).
The effect of cell and IgG transfer on fatty-streak
formation and VCAM-1 expression. Early fatty streaks in
mice immunized and boosted with HSP65 were signifi-
cantly larger (25,000 6 6,380 mm2) than their control
immunized littermates (2,000 6 1,400 mm2; p , 0.01) (Fig.
2). Mice transferred with HSP65-reactive lymph node cells
developed fatty streaks that were significantly larger than
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their control BSA-injected littermates (Table 1). Sera from
mice administered with lymph-node-reactive HSP65 did
not display reactivity to HSP65 by ELISA (data not
shown). Mice administered with anti-HSP65 splenocytes
had larger fatty streaks in comparison with the animals
given spleen cells reactive with BSA. Anti-HSP65 antibod-
ies were undetectable in the sera of mice injected with
HSP65-reactive splenocytes (data not shown).
Immunoglobulin G from serum of HSP65-immunized
mice also enhanced fatty-streak size as compared with
control IgG administration. Immunoglobulin G anti-
HSP65 levels obtained upon sacrifice were 1.2 6 0.2 (70%
of the binding evident in the donor mice immunized with
HSP65).
Expression of VCAM-1 was increased compared with
controls in slides obtained from mice transferred with
anti-HSP65 lymph node cells. Mean surface coverage of
plaque with VCAM-1 in the lymph node-HSP65 recipients
was 45 6 7% versus 31 6 1% 6 6% in the lymph-node BSA
recipients (p , 0.05). No differences in the extent of
staining to ICAM-1 and E-Selectin were evident between
the groups.
Immunoglobulin G from HSP65-immunized mice
(cross-reactive with mammalian HSP60) but not control
IgG immunostained aortic sinus endothelial cells, thus
confirming the expression of HSP60 (Fig. 3).
DISCUSSION
In the current study we provide evidence for the proathero-
genic role of the HSP65-specific cellular and humoral
responses in mice. Immunization with HSP65 in a protocol
similar to the one we employed in C57BL/6 mice (8) led to
acceleration of fatty-streak formation in the LDL-RD mice.
Adoptive transfer of lymphocytes obtained from lymph
nodes (representing the primary immune response to
HSP65) and from splenocytes (marking a tertiary response
to HSP65) increased the size of the fatty-streak lesions in
the recipient mice.
Evidence linking HSP65 with atherogenesis. Recently,
several laboratories have provided evidence for the involve-
Figure 1. Characterization of heat shock protein 65 (HSP65) reactivity of
lymphocytes and immunoglobulin G (IgG) employed for the transfer
experiments. Reactivity of lymph-node cells (A) and splenocytes (Spl) (B)
was determined by thymidine incorporation, whereas IgG binding was
defined by enzyme-linked immunosorbent assay. BSA 5 bovine serum
albumin.
Figure 2. Fatty-streak formation in mice immunized with heat shock
protein 65 (HSP65) or bovine serum albumin (BSA). Sections from mice
immunized and boosted twice with HSP65 or BSA were stained with
oil-red O. Lesion area was assessed by an unbiased observer using a grid.
Table 1. Effect of Cell and IgG Transfer on Atherogenesis in
LDL-RD Mice
Anti-HSP65 Anti-BSA
Lymph node cell transfer (mm2) 17,500 6 4,750* 3,575 6 770
Spleen cell transfer (mm2) 20,000 6 3,850† 5,000 6 2,825
IgG transfer (mm2) 17,000 6 3,250‡ 6,010 6 2,800
*p , 0.01 compared with control; †p 5 0.01 compared with control; ‡p , 0.05
compared with control.
BSA 5 bovine serum albumin; HSP65 5 heat shock protein 65; IgG 5
immunoglobulin G.
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ment of HSP60/65 in atherogenesis. Clinical observations
implied that the anti-HSP65 antibodies were associated
with enhanced carotid atherosclerosis as detected by sono-
graphic studies (3). Experimental data demonstrated that
immunization of rabbits and mice with mycobacterial
HSP65 led to arteriosclerotic lesions (7,8). The induced
lesions were rich in CD3-positive cells, thus attesting for
their inflammatory phenotype. It has been postulated that
stress-induced expression of host HSP60 targeted by an
anti-HSP65 immune response elements acts to enhance
atherosclerosis. However, both these studies in which my-
cobacterial HSP65 was used for immunization could not
address questions that pertain to the mechanisms mediating
the proatherogenic effect. In the present study we have
shown that HSP65-reactive lymph node and spleen cells
and IgG were potent in promoting fatty-streak formation in
the LDL-RD mouse model.
HSP expression in plaques of LDL RD mice as a trigger
of T cell activation. A recently perceived paradigm holds
that T-helper (Th) cells could be differentiated functionally
according to their cytokine secreting profile (17). Thus, Th
1 cells are discerned by production of cytokines such as
IFN-gamma and IL-2, whereas Th 2 cells favor production
of IL-4 and IL-10. The dichotomy has also recently been
observed in hypercholsterolemic apoE-deficient mice (18).
In atherosclerosis, it appears that a predominant Th 1
pattern is accompanied by increased atherosclerosis (19,20).
A possible proatherogenic effect of anti-HSP65 lymph node
and spleen cells could thus derive from ligation of these cells
by (cross-reactive) HSP60 expressed by the host (the
mouse) at areas of shear stress. The existence of this
interaction is evident by the ability of IgG from HSP65- but
not from BSA-immunized mice to immunostain the endo-
thelial surface of aortic sinus sections (Fig. 3). Once ligation
of the T-cell receptor occurs, a shift towards proatherogenic
(Th 1) cytokine secretion could follow, which may result in
accelerated atherosclerosis. Evidence for the role of T cells
in atherogenesis has been presented by several authors
(14,21–23). Our study, however, provides the first evidence
for antigen (HSP65)-specific T-cells influencing fatty-
streak formation in vivo.
Anti-HSP65 antibodies enhance fatty-streak formation.
We have observed in the present study that IgG anti-
HSP65 antibodies could accelerate fatty streaks in recipient
mice. Immunoglobulin G HSP65 antibodies can be formed
in response to infections and react with self-HSP-60. In
Figure 3. Immunohistochemical detection of heat shock protein (HSP)60/65. Immunoglobulin G (IgG) was purified from the sera of mice immunized with
HSP65. Purified IgG was cross-reactive with HSP60 employing enzyme-linked immunosorbent assay. The IgG from HSP65 immunized mice was used
to immunostain aortic sinus sections from low density lipoprotein receptor-deficient mice with the Histomouse kit. (A) Positive staining of the endothelial
cells; (B) a similar section stained with control mouse IgG.
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humans, levels of anti-HSP65 antibodies correlate with
carotid atherosclerosis (24) and their sustained presence
appears to predict mortality among atherosclerotic patients
(25). These observations are supported by in vitro studies:
anti-HSP60/65 antibodies have functional properties that
render them potentially atherogenic as they mediate endo-
thelial cytotoxicity (11,12). These observations may provide
a mechanism of action of these antibodies that may induce
endothelial expression of adhesion molecules, followed by
monocyte attraction and foam-cell formation. Furthermore,
it would be interesting to study the combined effect of
cellular and humoral immune responses to HSP65, as they
may act synergistically on atherosclerosis progression.
Conclusions and prospects. In conclusion, we provide a
direct proof that the lymphocytes and IgG reactive with
HSP65 can promote fatty-streak formation in the
LDL-RD mouse. These data also justify a separate analysis
of the association between cellular immunity to HSP65 and
atherosclerosis in humans, similar to the studies evaluating
the relation of anti-HSP65 antibodies and atherosclerosis.
Furthermore, this study provides additional evidence re-
garding the operability of autoimmune mechanisms in the
early stages of atherosclerosis.
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